11 employees
Exheus is provider of direct-to-consumer gene expression report that helps to optimise people’s health in a highly personalised way.
2020
$674K
from 4 investors over 4 rounds
Exheus raised $674K on November 29, 2022
Investors: Decelera, WA4STEAM and Capital Cell
Exheus raised undisclosed on May 31, 2021
Investors: Google Developers Launchpad Program